Skip to main content
. 2019 Jul 17;14(7):e0218944. doi: 10.1371/journal.pone.0218944

Fig 3. FoxP3+ mTregs inhibits cell migration, invasion and relative wound density (RWD) in injured human endothelial cells (ECs).

Fig 3

ECs were treated with MSCs [3A (a, start 3hrs; b, end 30hrs)] or FoxP3+ mTregs [3A (c, start 3hrs; d, end 30hrs)]. FoxP3+ mTregs inhibit RWD in injured human ECs (3B) and S1 Data.